Related Experiment Video
Updated: Aug 23, 2026

Modeling Spontaneous Metastatic Renal Cell Carcinoma (mRCC) in Mice Following Nephrectomy
Published on: April 29, 2014
Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2
Eriko Fujimoto1, Haruna Satoh, Etsuko Negishi
1Faculty of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
Abstract:
Connexin (Cx) genes have negative growth effects on tumor cells with certain cell specificity. We have previously reported that Cx32 is specifically downregulated in human renal cell carcinoma cell (RCC) lines as well as cancerous regions of kidneys and that the Cx is expressed in the progenitor cells of the carcinoma. However, the precise role of Cx32 in growth control of RCC cells remains unknown. In this study, we examined whether Cx32 could act in growth control against a human RCC cell, Caki-2 cell. In order to estimate the cell growth control, we established Caki-2 cells that have stable expression of Cx32 genes. Cx32 expression in Caki-2 cells induced contact inhibition of growth and reduced anchorage-independent growth ability, but did not significantly affect lag phase growth rates. This growth control by Cx32 was dependent on the inhibition of the cell-cycle transition from G1 to S phase at high cell density, and the inhibition of the cell-cycle transition related to the suppression of Her-2 activation. Furthermore, the suppression of Cx32 expression in Caki-2 cells by short interfering RNA induced the activation of Her-2. These data suggest that Cx32 has negative growth control of Caki-2 cells, partly due to the inhibition of the Her-2 activation.
Insights
Connexin 32 (Cx32) suppresses renal cell carcinoma (RCC) growth by inhibiting cell-cycle progression and Her-2 activation. Restoring Cx32 in RCC cells promotes contact inhibition and reduces tumor cell proliferation.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- Connexin (Cx) genes exhibit cell-specific negative growth effects on tumor cells.
- Cx32 is downregulated in human renal cell carcinoma (RCC) and its progenitor cells.
- The specific role of Cx32 in RCC growth control is not fully understood.
Purpose of the Study:
- To investigate the growth-controlling function of Cx32 in human RCC cells.
- To determine the molecular mechanisms underlying Cx32-mediated growth inhibition in RCC.
Main Methods:
- Stable expression of Cx32 genes in Caki-2 RCC cells.
- Assessment of cell growth control, including contact inhibition and anchorage-independent growth.
- Cell-cycle analysis to determine the effect on G1 to S phase transition.
- Investigation of the role of Her-2 activation using short interfering RNA (siRNA).
Main Results:
- Cx32 expression induced contact inhibition and reduced anchorage-independent growth in Caki-2 cells.
- Cx32 inhibited cell-cycle transition from G1 to S phase at high cell density.
- Cx32-mediated growth control was linked to the suppression of Her-2 activation.
- Suppression of Cx32 by siRNA led to Her-2 activation.
Conclusions:
- Cx32 exerts negative growth control on Caki-2 RCC cells.
- This growth inhibition is partly mediated by suppressing Her-2 activation.
- Cx32 may serve as a potential therapeutic target for RCC.
Related Concept Videos
Mitogens and the Cell Cycle
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation